MDXH Stock Analysis: Buy, Sell, or Hold?
MDXH - MDxHealth SA Ordinary Shares
$0.43
0.01 (3.08%)
▲
5d:
-13.56%
30d:
-21.08%
90d:
-81.15%
WAIT
LOW Confidence
Analysis Updated: Jul 15, 2026 12:00 AM ET
Earnings: Aug 13, 2026
28d
Get Alerted When MDXH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: MDXH is down 13.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: MDXH is down 13.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: MDXH is currently trading at $0.43, which is considered oversold relative to its 30-day fair value range of $0.45 to $0.56.
Technical Outlook: Technically, MDXH is in a strong downtrend. The price is currently testing key support at $0.51. A bounce from this level would confirm strength, while a break below could signal further downside. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.90 (+598.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MDXH is in a strong downtrend. The price is currently testing key support at $0.51. A bounce from this level would confirm strength, while a break below could signal further downside. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.90 (+598.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.45 -
$0.56
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.1%)
- BULLISH: Trading 598.6% below Wall St target ($2.90)
- WARNING: Recommendation downgraded due to -13.6% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.45 -
$0.56
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.51
Resistance Level
$0.79
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.09
Wall Street Target
$2.90
(+598.6%)
Revenue Growth (YoY)
12.7%
Profit Margin
-29.9%
Share & Embed Analysis
Last updated: July 15, 2026 3:07 PM ET
Data refreshes hourly during market hours. Next update: 4:07 PM
Data refreshes hourly during market hours. Next update: 4:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MDXH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$591 | 64 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 68 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$157 | 60 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$271 | 58 HOLD |
